Cargando…

The interaction of vasoactive substances during exercise modulates platelet aggregation in hypertension and coronary artery disease

BACKGROUND: Acute vigorous exercise, associated with increased release of plasma catecholamines, transiently increases the risk of primary cardiac arrest. We tested the effect of acute submaximal exercise on vasoactive substances and their combined result on platelet function. METHODS: Healthy volun...

Descripción completa

Detalles Bibliográficos
Autores principales: Petidis, Konstantinos, Douma, Stella, Doumas, Michael, Basagiannis, Ilias, Vogiatzis, Konstantinos, Zamboulis, Chrysanthos
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2008
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2432046/
https://www.ncbi.nlm.nih.gov/pubmed/18505546
http://dx.doi.org/10.1186/1471-2261-8-11
Descripción
Sumario:BACKGROUND: Acute vigorous exercise, associated with increased release of plasma catecholamines, transiently increases the risk of primary cardiac arrest. We tested the effect of acute submaximal exercise on vasoactive substances and their combined result on platelet function. METHODS: Healthy volunteers, hypertensive patients and patients with coronary artery disease (CAD) performed a modified treadmill exercise test. We determined plasma catecholamines, thromboxane A(2), prostacyclin, endothelin-1 and platelet aggregation induced by adenosine diphosphate (ADP) and collagen at rest and during exercise. RESULTS: Our results during exercise showed a) platelet activation (increased thromboxane B(2), TXB(2)), b) increased prostacyclin release from endothelium and c) decreased platelet aggregation in all groups, significantly more in healthy volunteers than in patients with CAD (with hypertensives lying in between these two groups). CONCLUSION: Despite the pronounced activation of Sympathetic Nervous System (SNS) and increased TXB(2 )levels during acute exercise platelet aggregation decreases, possibly to counterbalance the prothrombotic state. Since this effect seems to be mediated by the normal endothelium (through prostacyclin and nitric oxide), in conditions characterized by endothelial dysfunction (hypertension, CAD) reduced platelet aggregation is attenuated, thus posing such patients in increased risk for thrombotic complications.